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Circulating BDNF is higher in women than in men and suggested to be aﬀected by changes in food intake, body weight, and
exercise. ,e purpose of this study was to compare BDNF concentrations in women and men during a 12-week weight loss
intervention. Using a previously published 12-week randomized study, serum BDNF was assessed at baseline and after 12 weeks
using an enzyme-linked immunosorbent assay method. Fifty overweight or obese but healthy individuals (26 women, mean age of
36.4± 7.9 years; 24 men, mean age of 38.0± 5.9 years) were included and allocated into three groups: exercise-only (EXO; 12 weeks
of aerobic exercise and isocaloric diet), diet-only (DIO; 8 weeks of very low energy diet (VLED 600 kcal/day) followed by a 4-week
weight maintenance diet), or diet and exercise (DEX; 12 weeks of aerobic exercise in parallel with 8 weeks of VLED (800 kcal/day)
followed by a 4-week weight maintenance diet). At baseline, BDNF levels were 25% higher in women compared to men
(p � 0.006). Body weight was reduced in all intervention groups (p< 0.006). Exercise (EXO group) induced a 22% reduction in
circulating BDNF inmen (p � 0.037) and women (p � 0.080). In the DIO and DEX groups, a signiﬁcant reduction in BDNF levels
(29.9%; p � 0.035 and 32.5%; p � 0.003, respectively) was observed in women but not in men. In conclusion, circulating BDNF
was signiﬁcantly changed by diet alone or combined with exercise in women and only by exercise alone in men.,is suggests that
changes in circulating BDNF depend on weight loss methods (diet/exercise) as well as sex.
1. Introduction
Recent evidence has suggested an association between
obesity and impaired cognitive functions [1]. In line with
this, weight loss using exercise and diet has among other
beneﬁcial health-related eﬀects been shown to improve
cognitive functions [2]. Several of the biological mechanisms
behind these ﬁndings are still unknown. However, there is
accumulating evidence that brain-derived neurotrophic
factor (BDNF) is involved in mediating the beneﬁts of ex-
ercise and reduced food intake on cognitive functions [3, 4].
BDNF is a member of the nerve growth factor- (NGF-)
related family expressed in the central nervous system (CNS)
and peripheral nervous system (PNS) [5]. BDNF has a
central role in neuronal outgrowth, diﬀerentiation, neuronal
repair, and synaptic connection [6]. Further, loss-of-func-
tion mutations in the BDNF receptor (high-aﬃnity tropo-
myosin-related kinase B (TrkB)) can cause diseases, such as
depression and neurodegenerative disorders as well as
obesity and eating disorders [3, 5, 7]. Sex diﬀerences have
been shown to aﬀect circulating BDNF [8, 9], with higher
circulating BDNF in women, compared with men [10].
A high level of circulating BDNF has been linked to a
healthy lifestyle and a low level of BDNF has been associated
with metabolic risk factors and eating disorders [3, 11]. In
recent studies, conﬂicting data have modiﬁed the associa-
tions with low BDNF in overweight individuals [12–14].
Research is needed to clarify the BDNF levels in overweight
induced by diﬀerent factors according to sex. No ran-
domized studies have investigated the combined eﬀect of
Hindawi
Journal of Obesity
Volume 2019, Article ID 4537274, 7 pages
https://doi.org/10.1155/2019/4537274
diet and exercise in overweight on circulating BDNF levels,
according to sex.
Due to conﬂicting results in circulating BDNF, we hy-
pothesized that BDNF levels after weight loss will be sig-
niﬁcantly diﬀerent according to sex. ,e aim of this analysis
was to investigate if weight loss in overweight and obese
participants, induced by a 12-week intervention of either
aerobic exercise, energy-restricted diet, or a combination of
both, would aﬀect circulating BDNF and if sex had any
eﬀects that would modify the weight loss eﬀect.
2. Subjects and Methods
2.1. Participants. ,e primary study is described in detail in
the study of Christiansen et al. [15]. In this study, we in-
cluded 26 women (mean age of 36.4± 7.9 years) and 24 men
(mean age of 38.0± 5.9 years) who completed the primary
study and who had serum available for the BDNF analyses.
,e participants were weight-stable (±2 kg of current body
weight), were physically able to complete the exercise
programme, and received no medication aﬀecting meta-
bolism. ,e women included were fertile and in diﬀerent
phases of their menstrual cycle during blood sampling and
BDNF assessment; however, given the long intervention (12
weeks) and randomization, the eﬀect of the hormonal
changes during the study is considered to be of minor
importance. Participants were excluded if they were di-
agnosed with cardiovascular disease, were diagnosed with
type 2 diabetes (T2D), or were pregnant. All gave written
informed consent before the participation.
,e participants were randomized to a 12-week in-
tervention consisting of either aerobic exercise (EXO), en-
ergy-restricted diet (DIO), or a combination of both (DEX).
Baseline data were collected at ﬁrst day of the 12-week
intervention.
2.2. Exercise. In the EXO and DEX groups, the exercise
consisted of supervised aerobic exercise three times per week
with a duration of 60–75min per training session, an esti-
mated energy expenditure of 500–600 kcal per session, and
an intensity of 70% of heart rate reserve [16].
2.3.Diet. In the DIO and DEX groups, the diet consisted of a
liquid very low energy diet (VLED; Nupo, Copenhagen,
Denmark) of 600 or 800 kcal/day, respectively (49.6 E%
protein, 35.1 E% carbohydrates, and 15.2 E% fat) for 8 weeks
followed by a weight maintenance diet for 4 weeks [15]. ,e
weight maintenance diet was determined by estimating
resting energy expenditure multiplied by a factor of 1.5 for
subjects in the DIO group and 2.5 in the DEX group. In the
EXO group, dietary advice was given to maintain an iso-
caloric diet for the duration of the intervention.
2.4. BDNF Assay. ,e Quantikine ELISA Human Free
BDNF immunoassay (DBD00, R&D Systems, Abingdon
OX14, UK) was used for the BDNF analysis according to the
manufacturers’ instructions. Serum was diluted 1 : 20 for the
analyses. ,e intra- and interassay CV was 5.0% and 11.3%,
respectively, and all samples were tested in doublet to
minimize the interassay variability.
2.5. Statistical Analysis. Baseline data are presented as
mean± standard deviation (SD), and changes from baseline
to week 12 are presented as mean with 95% conﬁdence
interval (CI). Normality of data was tested with the
Shapiro–Wilk test. Independent t-test and Mann–Whitney
U test were used to test for sex diﬀerence.
Pearson and Spearman correlations were performed
to investigate correlations between BDNF, anthropo-
metric, metabolic, and adipose tissue markers in relation
to gender. For any signiﬁcant correlation, linear re-
gression was performed to test for predictors for BDNF.
Paired-sample t-tests and Wilcoxon test were performed
to investigate any signiﬁcant change from baseline to
week 12.
One-way ANOVAwas performed to test for interactions
between women and men.
Two-way ANOVAwas performed to test for interactions
between sex and intervention groups.
p values below 0.05 were considered statistically sig-
niﬁcant. All statistical analyses were performed with the
statistical software package SPSS (Chicago, IL, USA).
3. Results
,e analyses included 26 women, who were 36.4± 7.9 years
and had a mean BMI of 35.7± 3.1 kg/m2, and 24 men, who
were 38.0± 5.9 years and had a BMI of 32.3± 2.6 kg/m2.
At baseline, serum BDNF concentrations were higher in
women, 21.7± 7.5 ng/mL, compared to men, 16.3± 5.7 ng/
mL (p< 0.01; Figure 1).
In men and women, weight decreased in all intervention
groups with the largest weight loss for men in the DIO group
with − 14.3± 2.9 kg (p< 0.001) and for women in the DEX
group with − 11.4± 5.2 kg (p< 0.001, Table 1). Men had the
largest chance in weight loss and BMI across all groups:
EXO, DEX, and DIO (Table 1).
In the EXO group, circulating BDNF decreased by
22.1% in men (p< 0.05) and 22.4% in women (p � 0.1,
Table 2). In the DIO group, circulating BDNF decreased by
29.9% in women (p< 0.05), but no signiﬁcant eﬀect was
observed in men (Table 2). In the DEX group, circulating
BDNF decreased by 32.5% in women (p< 0.01), but no
signiﬁcant eﬀect was observed in men (Table 2). When
comparing the three groups by ANCOVA, we found no
signiﬁcant diﬀerence in the change in BDNF levels
(Table 2).
In men, insulin decreased signiﬁcantly in the DIO
group (p< 0.05), and in women, insulin decreased sig-
niﬁcantly in the DIO and DEX groups (p< 0.05, p< 0.05,
Table 1).
In men and women, glucose levels were signiﬁcantly
decreased in the DIO group (p< 0.05, p< 0.01, Table 1). For
men in the EXO group, there was a positive correlation
between ΔBDNF and ΔGlucose (p< 0.05, Figure 2).
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4. Discussion
At present, only a few human studies have investigated the
impact of sex and a combination of exercise and diet on
circulating BDNF. ,e present investigation is to our
knowledge the ﬁrst long-term randomized exercise and diet
study to demonstrate the sex-dependent eﬀect on serum
BDNF in healthy overweight or obese subjects.
Overall, and in accordance with other studies
[10, 17, 18], we observed ∼25% higher serum BDNF levels in
women compared to men, conﬁrming that circulating
BDNF is sex dependent. It has been shown previously that
women have a higher expression of BDNF in several brain
regions [18, 19], a diﬀerence that may be explained by es-
trogen-induced eﬀects on BDNF signaling pathways [20]
and an estrogen-speciﬁc eﬀect on BDNF levels found in
animal studies [21]. In line with these hormonal eﬀects,
women have been shown to have higher circulating BDNF
levels in the last phase of their menstrual cycle compared to
the ﬁrst phase [22]. ,ese ﬁndings suggest that gonadal
hormones could inﬂuence the sex diﬀerence found in cir-
culating BDNF levels.
Aerobic exercise was in our study found to reduce serum
BDNF levels signiﬁcantly with 22% in men. Most of other
current studies have not investigated the eﬀects of sex dif-
ferences and exercise but analyzed either men or women.
However, rodent studies have found higher BDNF mRNA
expression and circulating BDNF levels after 5 months of
voluntary wheel running in males compared to female mice
[23] In humans, and similar to our ﬁndings, Damirchi et al.
showed a decrease in circulating BDNF in men after aerobic
exercise [24], and the meta-analysis of 29 studies by Szuhany
et al. agreed on an increase in BDNF after exercise in men,
but not in women [4]. Although we found the same relative
change in circulating BDNF in women and men, other
studies have observed sex diﬀerences in the BDNF response
related to the intensity of the exercise performed, where high
intensity has been found to cause the largest sex diﬀerence
[25, 26]. ,ese ﬁndings could indicate that men are able to
obtain higher BDNF levels with increasing intensity of the
exercise, which may be explained by the relatively higher
muscle mass in men, acknowledging that BDNF may play a
role as a regulator of metabolism in skeletal muscle in
humans [27]. In addition, a recent study found that low
adipose tissue mass was associated with increased BDNF
levels in male mice [28]. ,is sex diﬀerence in relation to
adipose tissue mass may contribute to some of the sex
diﬀerences observed in our study after aerobic exercise [29].
A recent study by Golden et al. with obese adolescents
showed no sex-dependent eﬀect of either resistance or
aerobic exercise [30]. In contrast, circulating BDNF levels
increased in women above 45 years after 6 months of aerobic
exercise, whereas levels decreased in men [31]. ,ese
ﬁndings, with age-related diﬀerences, could indicate that age
has an impact on the sex diﬀerence found in BDNF levels
after aerobic exercise. Further studies are needed to in-
vestigate the association between circulating BDNF levels,
exercise, sex, and the inﬂuence of age.
We found a signiﬁcant 30% reduction in circulation
BDNF levels in women after the VLED-induced weight loss.
In rodents, BDNF expression in the ventromedial hypo-
thalamus has been shown to be regulated by nutritional
status [32] and to reduce glucose levels after a high-fat diet
[33, 34]. Additionally, sex-speciﬁc research in rodents found
lower glucose and higher BDNF expression in women
compared to men after a high-fat diet [35] In line with these
ﬁndings, our human study found similar changes in glucose
(Table 2), and in men, a signiﬁcant correlation between
change in glucose and change in BDNF after exercise was
found. ,e abovementioned ﬁndings may suggest that
BDNF levels are related to changes in energy balance in-
cluding changes in glucose and insulin levels. Whether the
observed sex diﬀerences in BDNF in our study are caused by
sex diﬀerences related to glucose metabolism is not possible
to determine from the current literature.
,e ﬁndings in the present study conﬁrm the ﬁndings in
other human studies with a reduction in circulating BDNF
in women after weight loss. Merhi et al. [12] showed a ∼50%
decrease in circulating BDNF levels in 18 morbidly obese
women 3 months after bariatric surgery and a 12.6% de-
crease in BMI. In contrast, Harvie et al. [36] found no change
in serum BDNF after either intermittent or continuous
energy restriction in overweight women. In that study, the
intervention with a 25% continuous energy restriction over 6
months resulted in a 3.5% weight loss [36], opposed to the
10% weight loss found in our study where participants
followed a VLED for 8 weeks. Changes in body weight in
humans have been shown to aﬀect BDNF levels [9, 37], and
the present ﬁndings suggest that the eﬀect of weight loss on
circulating BDNF might depend on the level of energy re-
striction. Further research in that potential dose-response
relationship is needed in order to understand the relations
between BDNF levels and energy restriction.
,e combination of aerobic exercise and VLED showed a
highly signiﬁcant 32% decrease in circulating BDNF in
women with no change in men. ,e present study is the ﬁrst
0.00
10.00
20.00
30.00
40.00
BD
N
F 
(n
g/
m
L)
Women Men
∗∗
Figure 1: Baseline serum BDNF. Boxplot of average (±standard
error) of serum BDNF levels in women (21.7± 7.5 ng/mL) and men
(16.3± 5.7 ng/mL). Signiﬁcant diﬀerence (p � 0.006) is marked
with two stars. Independent t-test was used to test for signiﬁcant sex
diﬀerence.
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human study to combine exercise and diet in relation to
circulating serum BDNF levels in healthy overweight or
obese female and men. However, animal studies have pre-
viously investigated the combined eﬀect of diet and exercise
on BDNF levels. Wu et al. demonstrated that dietary sup-
plement of docosahexaenoic acid combined with voluntary
exercise increased BDNF levels in rats [38]. Additionally,
voluntary exercise has been found to reverse the eﬀects of
high-fat diet on circulating BDNF in female rats [39]. ,is
suggests that the eﬀect of diet can be enhanced by the ad-
dition of exercise and might overrule the negative eﬀects of a
high-fat diet.
,e strength of the present study is the randomized
design, sex-segregated analysis, monitored diet, and su-
pervised exercise session [15]. ,ere are also some limita-
tions to the study, including the small group of each sex.
,ere is an ongoing discussion in the literature on the choice
of serum vs. plasma for the measurement of circulating
BDNF. It has been shown that exercise inﬂuenced serum
BDNF levels more than the plasma levels [40, 41] Studies
have suggested that serum presents a more complete amount
of circulating BDNF levels compared with plasma, since
BDNF is picked up by platelets from the circulating BDNF
[42]. However, a recent study showed high reliability in
serum measurements of BDNF [43].
5. Conclusion
In this secondary analysis, both diet and diet together with
exercise changed circulating BDNF levels signiﬁcantly in
women only. Exercise alone altered circulating BDNF in
men but only showed a trend in women. When comparing
the additional eﬀects of energy restriction in women on
circulating BDNF, it would be of interest in future studies to
investigate if a weight loss (or energy restriction) threshold
exists. Additionally, it would be of interest to investigate if
the lifestyle-induced changes in peripheral BDNF levels are
mirrored by changes in BDNF levels in the central nervous
system.
Data Availability
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available from the corresponding author upon request.
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